The Estimation of Melting Points and Fusion Enthalpies Using Experimental Solubilities, Estimated Total Phase Change Entropies, and Mobile Order and Disorder Theory
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Campro Catalog Stable Isotope
Introduction & Welcome Dear Valued Customer, We are pleased to present to you our Stable Isotopes Catalog which contains more than three thousand (3000) high quality labeled compounds. You will find new additions that are beneficial for your research. Campro Scientific is proud to work together with Isotec, Inc. for the distribution and marketing of their stable isotopes. We have been working with Isotec for more than twenty years and know that their products meet the highest standard. Campro Scientific was founded in 1981 and we provide services to some of the most prestigious universities, research institutes and laboratories throughout Europe. We are a research-oriented company specialized in supporting the requirements of the scientific community. We are the exclusive distributor of some of the world’s leading producers of research chemicals, radioisotopes, stable isotopes and environmental standards. We understand the requirements of our customers, and work every day to fulfill them. In working with us you are guaranteed to receive: - Excellent customer service - High quality products - Dependable service - Efficient distribution The highly educated staff at Campro’s headquarters and sales office is ready to assist you with your questions and product requirements. Feel free to call us at any time. Sincerely, Dr. Ahmad Rajabi General Manager 180/280 = unlabeled 185/285 = 15N labeled 181/281 = double labeled (13C+15N, 13C+D, 15N+18O etc.) 186/286 = 12C labeled 182/282 = d labeled 187/287 = 17O labeled 183/283 = 13C labeleld 188/288 = 18O labeled 184/284 = 16O labeled, 14N labeled 189/289 = Noble Gases Table of Contents Ordering Information.................................................................................................. page 4 - 5 Packaging Information .............................................................................................. -
High Temperature Enthalpies of the Lead Halides
HIGH TEMPERATURE ENTHALPIES OF THE LEAD HALIDES: ENTHALPIES AND ENTROPIES OF FUSION APPROVED: Graduate Committee: Major Professor Committee Member Min fessor Committee Member X Committee Member UJ. Committee Member Committee Member Chairman of the Department of Chemistry Dean or the Graduate School HIGH TEMPERATURE ENTHALPIES OF THE LEAD HALIDES: ENTHALPIES AND ENTROPIES OF FUSION DISSERTATION Presented to the Graduate Council of the North Texas State University in Partial Fulfillment of the Requirements For the Degree of DOCTOR OF PHILOSOPHY By Clarence W, Linsey, B. S., M. S, Denton, Texas June, 1970 ACKNOWLEDGEMENT This dissertation is based on research conducted at the Oak Ridge National Laboratory, Oak Ridge, Tennessee, which is operated by the Uniofl Carbide Corporation for the U. S. Atomic Energy Commission. The author is also indebted to the Oak Ridge Associated Universities for the Oak Ridge Graduate Fellowship which he held during the laboratory phase. 11 TABLE OF CONTENTS Page LIST OF TABLES iv LIST OF ILLUSTRATIONS v Chapter I. INTRODUCTION . 1 Lead Fluoride Lead Chloride Lead Bromide Lead Iodide II. EXPERIMENTAL 11 Reagents Fusion-Filtration Method Encapsulation of Samples Equipment and Procedure Bunsen Ice Calorimeter Computer Programs Shomate Method Treatment of Data Near the Melting Point Solution Calorimeter Heat of Solution Calculations III. RESULTS AND DISCUSSION 41 Lead Fluoride Variation in Heat Contents of the Nichrome V Capsules Lead Chloride Lead Bromide Lead Iodide Summary BIBLIOGRAPHY ...... 98 in LIST OF TABLES Table Pa8e I. High-Temperature Enthalpy Data for Cubic PbE2 Encapsulated in Gold 42 II. High-Temperature Enthalpy Data for Cubic PbF2 Encapsulated in Molybdenum 48 III. -
Anabolic-Androgenic Steroids in Horses: Natural Presence and Underlying Biomechanisms
ANABOLIC-ANDROGENIC STEROIDS IN HORSES: NATURAL PRESENCE AND UNDERLYING BIOMECHANISMS Anneleen Decloedt Dissertation submitted in the fulfilment of the requirements for the degree of Doctor of philosophy (PhD) in Veterinary Sciences, Faculty of Veterinary Medicine, Ghent University PROMOTER Prof. dr. ir. Lynn Vanhaecke Ghent University, Faculty of Veterinary Medicine Department of Veterinary Public Health and Food Safety Laboratory of Chemical Analysis MEMBERS OF THE READING COMMITTEE Prof. dr. James Scarth HFL Sport Science, Cambridgeshire, United-Kingdom Prof. dr. Peter Van Eenoo Ghent University, DoCoLab, Zwijnaarde, Belgium Prof. dr. Ann Van Soom Ghent University, Faculty of Veterinary Medicine, Merelbeke, Belgium MEMBERS OF THE EXAMINATION COMMITTEE Dr. Ludovic Bailly-Chouriberry Laboratoires des Courses Hippiques, Verrières-le-Buisson, France Dr. Leen Van Ginkel Wageningen University, RIKILT, Wageningen, The Netherlands Prof. dr. Myriam Hesta Ghent University, Faculty of Veterinary Medicine, Merelbeke, Belgium This work was funded by the Fédération Nationale des Courses Françaises (via the Laboratoire des Courses Hippiques) and executed at the Laboratory of Chemical Analysis (Faculty of Veterinary Medicine, Ghent University, Merelbeke). The author and the promoter give the authorisation to consult and to copy parts of this work for personal use only. Every other use is subject to the copyright laws. Permission to reproduce any material contained in this work should be obtained from the author. “The universe is full of magic, Just patiently waiting for our wits to grow sharper” TABLE OF CONTENTS TABLE OF CONTENTS Chapter I – General Introduction 1 1. Steroids 3 1.1 Chemical structure 1.2 (Steroid) hormones and their role in the endocrine system 1.3 Biosynthesis of steroid hormones 1.4 Anabolic-androgenic steroids (AAS) 1.5 Synthesis and absorption of the steroid precursor cholesterol 2. -
Quick Determination of 105 Doping in Animal Derived Food By
QTRAP®质谱系统对动物源食品中105种兴奋剂的快速分析 检测 Quick Determination of 105 Doping in Animal – derived Food by QTRAP® System 杨总1,陈丹2,程海燕1,李立军1,郭立海1 Yang Zong1,Chen Dan2,Cheng Haiyan1,Li Lijun1,Guo Lihai1 1 SCIEX亚太应用支持中心,上海; 2 湖北省武汉食品化妆品检验所 1 SCIEX Asia Pacific Application Support Center, Shanghai, China; 2 Wuhan Institute for Food and Cosmetic Control, Hubei Province, China; Keywords:doping;SCIEX QTRAP® 4500 系统; LC-MS/ MS;quantitative analysis 引言 在现代畜牧养殖业中,一些不法分子长期使用各种饲料添加 剂和人工合成激素类化合物,造成动物源食品中的药物残留,最 终成为食源性兴奋剂的来源[1]。运动员食用含有某些药物残留的食 物,可导致其兴奋剂检测呈阳性。国家反兴奋剂中心和世界反兴 奋剂机构(WADA)等组织机构明确规定了兴奋剂的违禁药物的种 SCIEX ExionLC™液相和SCIEX QTRAP® 4500质谱系统 类,主要包含了β-受体激动剂、固醇类激素、糖皮质激素、利尿 剂、玉米赤霉醇类等等。总体而言,兴奋剂的作用主要是对身体或 者中枢神经系统起到选择性的作用,能促进肌肉组织快速增长、增 4. 建立好了105种兴奋剂EPI二级谱库,软件自动进行匹配二级质 强机体活力和敏捷度,还可使运动员疲劳减轻,自信心增强,注意 谱图,保证筛查结果准确可靠; 力集中[2]。因此在体育赛事过程中,为了保证赛事结果的公平、公 正,在运动员食品安全保障过程中,必须对食品中兴奋剂进行严格 5. 方法现成,省去开发方法的时间,提高了工作效率; 的监控。本文针对动物源食品中的常见105种兴奋剂,建立了采用 QTRAP®系统快速筛查和定量方法,该方法完全满足在体育赛事过 1. 实验方法 程中对兴奋剂监管的分析要求。 1.1 液相色谱条件 该方案的特点和优势 色谱柱:Phenomenex Kinetex 2.6µm F5 100 Å 150×3 µm 流动相:水相(水中含有5 mM乙酸铵和0.01%甲酸),有机 1. 方法覆盖面广,包含了常见五大类β-受体激动剂、固醇类激 相为乙腈,梯度洗脱 素、糖皮质激素、利尿剂、玉米赤霉醇类兴奋剂,共105种; 1.2 质谱条件 2. 本实验详细优化了前处理过程,考察了化合物的稳定性; 扫描模式:MRM-IDA-EPI,正负离子同时扫描,MRM离子对见 3. 实验采用MRM-IDA-EPI扫描实现一针进样同时定量和定性分 表1。 析,快速灵敏,满足国内外标准品的要求; RUO-MKT-02-9756-ZH-A p 1 离子源:ESI源;离子源参数:喷雾电压(IS):5500V(+) 2. 结果与讨论 /-4500V(-);离子源温度:600℃;气帘气(CUR):35psi;碰 2.1 前处理过程的优化 撞气(CAD):Medium;雾化气(GS1):55psi;辅助雾化气 (GS2):60psi 本实验详细优化了前处理过程,实验结果表明在动物源食品 中酸化乙腈的提取效率最高,绝大部分化合物回收率在70%以上 1.3 样品前处理过程 (见图1、图2、图3)。由于基质的复杂性,实验比较了5种不同 称取5g样品于50 mL离心管 → 加入10 mL乙酸铵缓冲溶液混 的SPE柱的净化效率,由图4可以看出,PRIME HLB 净化效果最优 异,回收率较高。 匀 → 加入β-葡萄糖醛甙酶进行酶解 → 加入酸化乙腈进行提取, 震荡混匀后加入NaCl和Mg2SO4 → 萃取之后高速离心取上清液采用 PRIME HLB进行净化 → 吹干后复溶上机测试。 100 80 60 40 20 0 酸化叔丁基甲醚 酸化乙腈 碱化乙腈 图1. -
Chapter 11 Liquids, Solids, and Phase Changes
Lecture Presentation Chapter 11 Liquids, Solids, and Phase Changes 11.1, 11.2, 11.3, 11.4, 11.15, 11.17, 11.26, 11.30, 11.32, 11.40, 11.42, 11.60, 11.82, 11.116 John E. McMurry Robert C. Fay Properties of Liquids Viscosity: The measure of a liquid’s resistance to flow (higher intermolecular force, higher viscosity) Surface Tension: The resistance of a liquid to spread out and increase its surface area (forms beads) (higher intermolecular force, higher surface tension) Properties of Liquids low intermolecular force – low viscosity, low surface tension high intermolecular force – high viscosity, high surface tension HW 11.1 Properties of Liquids high intermolecular force – high viscosity, high surface tension For the following molecules which has the higher intermolecular force, viscosity and surface tension ? (LD structure, VSEPRT, dipole of molecule) (if the molecules are in the liquid state) a. CHCl3 vs CH4 b. H2O vs H2 (changed from handout) c. N Cl3 vs N H Cl2 Phase Changes between Solids, Liquids, and Gases Phase Change (State Change): A change in the physical state but not the chemical identity of a substance Fusion (melting): solid to liquid Freezing: liquid to solid Vaporization: liquid to gas Condensation: gas to liquid Sublimation: solid to gas Deposition: gas to solid Phase Changes between Solids, Liquids, and Gases Enthalpy – add heat to system Entropy – add randomness to system Phase Changes between Solids, Liquids, and Gases Heat (Enthalpy) of Fusion (DHfusion ): The amount of energy required to overcome enough intermolecular forces to convert a solid to a liquid Heat (Enthalpy) of Vaporization (DHvap): The amount of energy required to overcome enough intermolecular forces to convert a liquid to a gas HW 11.2: Phase Changes between Solids, Liquids, & Gases DHfusion solid to a liquid DHvap liquid to a gas At phase change (melting, boiling, etc) : DG = DH – TDS & D G = zero (bc 2 phases in equilibrium) DH = TDS o a. -
WO 2018/190970 Al 18 October 2018 (18.10.2018) W !P O PCT
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/190970 Al 18 October 2018 (18.10.2018) W !P O PCT (51) International Patent Classification: GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, CI2Q 1/32 (2006.01) UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (21) International Application Number: EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, PCT/US2018/021 109 MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (22) International Filing Date: TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, 06 March 2018 (06.03.2018) KM, ML, MR, NE, SN, TD, TG). (25) Filing Language: English Declarations under Rule 4.17: (26) Publication Langi English — as to applicant's entitlement to apply for and be granted a patent (Rule 4.1 7(H)) (30) Priority Data: — as to the applicant's entitlement to claim the priority of the 62/484,141 11 April 2017 ( 11.04.2017) US earlier application (Rule 4.17(Hi)) (71) Applicant: REGENERON PHARMACEUTICALS, Published: INC. [US/US]; 777 Old Saw Mill River Road, Tarrytown, — with international search report (Art. 21(3)) New York 10591-6707 (US). — with sequence listing part of description (Rule 5.2(a)) (72) Inventors: STEVIS, Panayiotis; 777 Old Saw Mill Riv er Road, Tarrytown, New York 10591-6707 (US). -
(12) Patent Application Publication (10) Pub. No.: US 2008/0063698 A1 Hartwig (43) Pub
US 2008 OO63698A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2008/0063698 A1 Hartwig (43) Pub. Date: Mar. 13, 2008 (54) CRYSTALLIZATION INHIBITION OF DRUGS now abandoned, which is a continuation of applica IN TRANSIDERMAL DRUG DELIVERY tion No. 10/010,342, filed on Dec. 5, 2001, now SYSTEMIS AND METHODS OF USE abandoned. (75) Inventor: Rod Lawson Hartwig, Plantation, FL (60) Provisional application No. 60/251.294, filed on Dec. (US) 5, 2000. Correspondence Address: Publication Classification Noven Pharmaceuticals, Inc. Jay G. Kolman, Esq. (51) Int. Cl. 11960 S.W. 144 Street A6II 3/56 (2006.01) A6F 3/00 (2006.01) Miami, FL 33186 (US) A6IP 43/00 (2006.01) (73) Assignee: NOVEN PHARMACEUTICALS, A6F 3/02 (2006.01) INC. (52) U.S. Cl. ........................... 424/448; 424/449; 514/170 (57) ABSTRACT Appl. No.: 11/897,189 (21) The invention relates to compositions and methods for (22) Filed: Aug. 29, 2007 making a transdermal drug delivery system capable of achieving substantially zero-order kinetics for delivery of Related U.S. Application Data the active agent over a period of time in excess of 24 hours and at least 72 hours, comprising a pharmaceutically accept (63) Continuation of application No. 10/751,152, filed on able active agent carrier and a rosin ester which provides a Jan. 2, 2004, now abandoned, which is a continuation crystal inhibiting and drug stabilizing effect on the active of application No. 10/353,624, filed on Jan. 29, 2003, agents incorporated therein. 13 2 2 Patent Application Publication Mar. -
Cryometric Determination of the Enthalpy of Fusion of Sodium Cryolite
Cryometric determination of the enthalpy of fusion of sodium cryolite M. MALINOVSKÝ Department of Chemical Technology of Inorganic Substances, Slovak Technical University, CS-812 37Bratislava Received 30 July 1982 Accepted for publication 22 August 1983 Using the method of classical thermal analysis a part of the liquidus of sodium cryolite in the system Na3AlF6—Na3FS04 was measured in the compo sition range 0—5 mole % Na3FS04. On the basis of these results the molar enthalpy of fusion of cryolite was calculated. It was found that AHf(Na3AlFft) = = 115.4 kJ mol"1; error in this result was estimated to be ±4.9 %. Методом классического термического анализа измерена часть ликви дуса натриевого криолита в системе Na3AlF6—Na3FS04 в интервале кон центраций 0—5 мол. % Na3FS04. На основании этих результатов рассчи тана мольная энтальпия плавления криолита. Найдено, что 1 AH,(Na3AlF6) = 115,4 кДж моль" ; точность этого результата ±4,9 %. Literature survey and theoretical Knowledge of the enthalpy of fusion of sodium hexafluoroaluminate Na3AlF6 (cryolite) is important both from theoretical and practical points of view. For example, it is needed at calculation of the thermal and energy balance and/or the thermal inertia of aluminium cells (the electrolyte contains about 90 mass % of Na3AlF6). The most precise values of the molar enthalpy of fusion AHf(i) of chemical substances can be generally obtained from calorimetric measurements. However, when we deal with substances having higher melting temperature and which are also unstable and very corrosive the calorimetric determination of the quantity AHf(i) can be less reliable. In the case of cryolite Roth and Bertram [1] found from the calorimetric 1 1 measurements ÄH,(Na3 A1F6) = 16.64 kcal mol" = 69.62 kJ mol" . -
Pharmaceutical Appendix to the Tariff Schedule 2
Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2007) (Rev. 2) Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names (INN) which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service (CAS) registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. ABACAVIR 136470-78-5 ACIDUM LIDADRONICUM 63132-38-7 ABAFUNGIN 129639-79-8 ACIDUM SALCAPROZICUM 183990-46-7 ABAMECTIN 65195-55-3 ACIDUM SALCLOBUZICUM 387825-03-8 ABANOQUIL 90402-40-7 ACIFRAN 72420-38-3 ABAPERIDONUM 183849-43-6 ACIPIMOX 51037-30-0 ABARELIX 183552-38-7 ACITAZANOLAST 114607-46-4 ABATACEPTUM 332348-12-6 ACITEMATE 101197-99-3 ABCIXIMAB 143653-53-6 ACITRETIN 55079-83-9 ABECARNIL 111841-85-1 ACIVICIN 42228-92-2 ABETIMUSUM 167362-48-3 ACLANTATE 39633-62-0 ABIRATERONE 154229-19-3 ACLARUBICIN 57576-44-0 ABITESARTAN 137882-98-5 ACLATONIUM NAPADISILATE 55077-30-0 ABLUKAST 96566-25-5 ACODAZOLE 79152-85-5 ABRINEURINUM 178535-93-8 ACOLBIFENUM 182167-02-8 ABUNIDAZOLE 91017-58-2 ACONIAZIDE 13410-86-1 ACADESINE 2627-69-2 ACOTIAMIDUM 185106-16-5 ACAMPROSATE 77337-76-9 -
Control Be Implemented. the First Large-Scale Systematic Olympic Games
Br J Sports Med: first published as 10.1136/bjsm.11.4.162 on 1 December 1977. Downloaded from 162 Brit. J. Sports Med. - Vol. 1 1, No. 4, December 1977, pp. 162-169 RADIOIMMUNOASSAY OF ANABOLIC STEROIDS: AN EVALUATION OF THREE ANTISERA FOR THE DETECTION OF ANABOLIC STEROIDS IN BIOLOGICAL FLUIDS Robert DUGAL, Ph.D., Claire DUPUIS, Ph.D. and Michel J. BERTRAND, Ph.D. Centre de Recherches en Sciences de la Sante, Institut National de la Recherche Scientifique, Centre Hospitalier Louis-H. Lafontaine, Montrdal, Quebec, Canada ABSTRACT Recently developped radioimmunoassays (RIA) for the analysis of anabolic steroids and their metabolites in biological fluids were tested for cross-reactivity with other types of steroids. Results show that the degree of desirable cross-reactivity within the two classes of orally active anabolic steroids vary widely and that the antiserum for 19-Nortestosterone (the active principle of intramuscular, preparations) has a very high degree of undesirable cross- reactivity with components of oral contraceptives. Single and multiple dose studies in human volunteers demonstrate that the detection level and degree of retrospectivity are likewise variable but that the test easily detects most anabolic steroids during treatment. At the present time, the combination of the three antisera for the assay of a sample appears to be a relatively rapid and economic method for screening large numbers of samples in situations where doping control of anabolic steroids is required. The importance of utilizing physico-chemical means for identification of RIA potential positives is emphasized. INTRODUCTION (Sumner, 1974: Brooks et al, 1975) and identification procedures for a limited number of them have also been copyright. -
Thermodynamic Temperature
Thermodynamic temperature Thermodynamic temperature is the absolute measure 1 Overview of temperature and is one of the principal parameters of thermodynamics. Temperature is a measure of the random submicroscopic Thermodynamic temperature is defined by the third law motions and vibrations of the particle constituents of of thermodynamics in which the theoretically lowest tem- matter. These motions comprise the internal energy of perature is the null or zero point. At this point, absolute a substance. More specifically, the thermodynamic tem- zero, the particle constituents of matter have minimal perature of any bulk quantity of matter is the measure motion and can become no colder.[1][2] In the quantum- of the average kinetic energy per classical (i.e., non- mechanical description, matter at absolute zero is in its quantum) degree of freedom of its constituent particles. ground state, which is its state of lowest energy. Thermo- “Translational motions” are almost always in the classical dynamic temperature is often also called absolute tem- regime. Translational motions are ordinary, whole-body perature, for two reasons: one, proposed by Kelvin, that movements in three-dimensional space in which particles it does not depend on the properties of a particular mate- move about and exchange energy in collisions. Figure 1 rial; two that it refers to an absolute zero according to the below shows translational motion in gases; Figure 4 be- properties of the ideal gas. low shows translational motion in solids. Thermodynamic temperature’s null point, absolute zero, is the temperature The International System of Units specifies a particular at which the particle constituents of matter are as close as scale for thermodynamic temperature. -
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0